Literature DB >> 17217327

Acute ischemic stroke: overview of recent therapeutic developments.

Nijasri Suwanwela1, Walter J Koroshetz.   

Abstract

Stroke, a disorder encompassing all cerebrovascular accidents, is a public health problem of immense proportions across the globe. Therapeutic efforts are directed at three aspects: prevention, acute treatment, and rehabilitation. Preventative measures, which in many instances mirror those for cardiovascular disease, can achieve the greatest public health impact. Measures that enhance the recovery of neurologic function and reduce neurologic disability after stroke can also affect a large population of handicapped stroke survivors. In the past 10 years, the greatest changes have occurred in the field of acute stroke treatment. Ultra-early-stage therapies with the potential to dramatically reverse severe neurologic deficits, or halt their progression, have caused a restructuring of the emergency care of neurologic patients. The parallels with the evolution of emergency treatment of acute coronary syndromes after 1970 are striking. This review focuses on aspects of stroke therapy that are either just entering, or soon to enter, current practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217327     DOI: 10.1146/annurev.med.58.070605.115306

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  15 in total

1.  CT interpretation by ASPECTS in hyperacute ischemic stroke predicting functional outcomes.

Authors:  Warinthorn Phuttharak; Kittisak Sawanyawisuth; Boonrerk Sangpetngam; Somsak Tiamkao
Journal:  Jpn J Radiol       Date:  2013-09-05       Impact factor: 2.374

2.  Intracellular ASIC1a regulates mitochondrial permeability transition-dependent neuronal death.

Authors:  Y-Z Wang; W-Z Zeng; X Xiao; Y Huang; X-L Song; Z Yu; D Tang; X-P Dong; M X Zhu; T-L Xu
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

3.  Neuronal IL-4Rα modulates neuronal apoptosis and cell viability during the acute phases of cerebral ischemia.

Authors:  Han Kyu Lee; Sehwon Koh; Donald C Lo; Douglas A Marchuk
Journal:  FEBS J       Date:  2018-05-24       Impact factor: 5.542

4.  BDNF mediates neuroprotection against oxygen-glucose deprivation by the cardiac glycoside oleandrin.

Authors:  Michael J Van Kanegan; Dong Ning He; Denise E Dunn; Peiying Yang; Robert A Newman; Anne E West; Donald C Lo
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

5.  Redox status in acute ischemic stroke: correlation with clinical outcome.

Authors:  Dalibor Paspalj; Petar Nikic; Milan Savic; Dragan Djuric; Igor Simanic; Vladimir Zivkovic; Nevena Jeremic; Ivan Srejovic; Vladimir Jakovljevic
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

Review 6.  Phytochemicals in Ischemic Stroke.

Authors:  Joonki Kim; David Yang-Wei Fann; Raymond Chee Seong Seet; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2016-05-18       Impact factor: 3.843

Review 7.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

8.  Angiopoietin-2 is vasoprotective in the acute phase of cerebral ischemia.

Authors:  Léna Marteau; Samuel Valable; Didier Divoux; Simon A Roussel; Omar Touzani; Eric T MacKenzie; Myriam Bernaudin; Edwige Petit
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-05       Impact factor: 6.200

9.  Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.

Authors:  Tao Peng; George L Britton; Hyunggun Kim; Davide Cattano; Jaroslaw Aronowski; James Grotta; David D McPherson; Shao-Ling Huang
Journal:  CNS Neurosci Ther       Date:  2013-08-24       Impact factor: 5.243

10.  Symptomatic unruptured isolated middle cerebral artery dissection: clinical and magnetic resonance imaging features.

Authors:  P H Gao; L Yang; G Wang; L Guo; X Liu; B Zhao
Journal:  Clin Neuroradiol       Date:  2014-09-06       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.